Literature DB >> 10872908

The reasoning behind decisions not to take up antiretroviral therapy in Australians infected with HIV.

R S Gold1, J Hinchy, C G Batrouney.   

Abstract

A substantial minority of HIV-infected Australians are not taking antiretroviral drugs. This study investigated the reasons behind their decision not to do so. Anyone who was HIV-infected but not taking antiretroviral drugs could participate. A self-administered, anonymous questionnaire was used, the principal recruitment method being through insertion of the questionnaire into gay community newspapers in Sydney and Melbourne. All respondents were asked questions covering demographics, previous AIDS-defining illnesses, T-cell and viral load monitoring, and previous use of antiretroviral drugs. In addition, respondents who had considered going on antiretroviral treatment, but then decided not to do so, were given a list of possible reasons for their decision and asked to indicate how much each played a role in their thinking. Of the 270 respondents, the great majority were gay men. One-eighth had experienced AIDS-defining illnesses. Two-thirds had recently had T-cell and viral load tests. One-third had taken antiretroviral drugs previously. Over two-thirds had considered antiretroviral therapy, most having given the matter quite some thought. Reasons for not taking up therapy did not differ greatly at different stages of HIV disease. The most common individual reason was fear of side effects. Important themes that emerged from factor analysis of the reasons data included distrust of conventional medical approaches to treatment, practical problems associated with taking antiretroviral drugs, unpleasant thoughts that being on therapy would evoke, and acceptance of the idea of dying. The findings can be used by doctors and counsellors to help patients clarify and evaluate their concerns about antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872908     DOI: 10.1258/0956462001916065

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  11 in total

1.  Medication-related barriers to entering HIV care.

Authors:  Linda Beer; Jennifer L Fagan; Pamela Garland; Eduardo E Valverde; Barbara Bolden; Kathleen A Brady; Maria Courogen; Daniel Hillman; Alan Neaigus; Jeanne Bertolli
Journal:  AIDS Patient Care STDS       Date:  2012-02-09       Impact factor: 5.078

2.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

3.  Assessing HIV and AIDS treatment safety and health-related quality of life among cohort of Malaysian patients: a discussion on methodological approach.

Authors:  Imran Ahmed Syed; Syed Azhar Syed Sulaiman; Mohammad Azmi Hassali; Christopher K C Lee
Journal:  Health Expect       Date:  2013-09-08       Impact factor: 3.377

4.  Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape.

Authors:  Jan Fehr; Dunja Nicca; Jean-Christophe Goffard; David Haerry; Michael Schlag; Vasileios Papastamopoulos; Andy Hoepelman; Athanasius Skoutelis; Ruth Diazaraque; Bruno Ledergerber
Journal:  Infection       Date:  2016-03-16       Impact factor: 3.553

5.  To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS.

Authors:  Heidemarie Kremer; Gail Ironson; Neil Schneiderman; Martin Hautzinger
Journal:  AIDS Patient Care STDS       Date:  2006-05       Impact factor: 5.078

6.  'Not Until I'm Absolutely Half-Dead and Have To:' Accounting for Non-Use of Antiretroviral Therapy in Semi-Structured Interviews with People Living with HIV in Australia.

Authors:  Christy E Newman; Limin Mao; Asha Persson; Martin Holt; Sean Slavin; Michael R Kidd; Jeffrey J Post; Edwina Wright; John de Wit
Journal:  AIDS Patient Care STDS       Date:  2015-03-25       Impact factor: 5.078

7.  Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study.

Authors:  Belay Tessema; Fantahun Biadglegne; Andargachew Mulu; Assefa Getachew; Frank Emmrich; Ulrich Sack
Journal:  AIDS Res Ther       Date:  2010-01-14       Impact factor: 2.250

8.  Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART.

Authors:  Matthew P Fox; Arthur Mazimba; Phil Seidenberg; Denise Crooks; Bornwell Sikateyo; Sydney Rosen
Journal:  J Int AIDS Soc       Date:  2010-03-06       Impact factor: 5.396

9.  Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.

Authors:  Linda Beer; Eduardo E Valverde; Jerris L Raiford; John Weiser; Becky L White; Jacek Skarbinski
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-11-12

10.  Why do marital partners of people living with HIV not test for HIV? A qualitative study in Lusaka, Zambia.

Authors:  Maurice Musheke; Sonja Merten; Virginia Bond
Journal:  BMC Public Health       Date:  2016-08-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.